• Invo Fertility filed audited, restated results, recasting 2025 quarterly financial statements for periods ended March 31, June 30, Sept. 30.
• Restatement followed an internal review that found classification and accounting errors tied to preferred stock, a convertible debenture, warrants, liabilities.
• Audit Committee concluded on June 1, 2026 that the previously issued quarterly financial statements should no longer be relied upon.
• Company indicated the errors did not affect revenue or loss from operations, citing no change to its business plan or operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028454), on June 12, 2026, and is solely responsible for the information contained therein.